| Price | 193.00p on 12-05-2026 at 16:30:00 |
|---|---|
| Change | 2.00p 1.05% |
| Buy | 193.00p |
| Sell | 188.50p |
| Last Trade: | Buy 3.00 at 193.00p |
| Day's Volume: | 29,592 |
| Last Close: | 193.00p |
| Open: | 199.50p |
| ISIN: | KYG4672N1198 |
| Day's Range | 189.00p - 199.50p |
| 52wk Range: | 189.00p - 292.00p |
| Market Capitalisation: | £1.66b |
| VWAP: | 189.29459p |
| Shares in Issue: | 859.75m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3 | 193.00p | Suspected BUY Trade |
16:35:22 - 12-May-26 |
| Sell* | 13,300 | 189.25p | Ordinary |
14:22:44 - 12-May-26 |
| Sell* | 13,300 | 189.00p | Ordinary |
14:22:35 - 12-May-26 |
| Sell* | 960 | 189.00p | Automatic Execution |
12:34:05 - 12-May-26 |
| Buy* | 600 | 189.895p | Ordinary |
12:33:44 - 12-May-26 |
| Buy* | 523 | 189.895p | Ordinary |
12:33:42 - 12-May-26 |
| Buy* | 20 | 189.97p | Ordinary |
12:33:41 - 12-May-26 |
| Buy* | 3 | 190.00p | SI Trade |
12:33:40 - 12-May-26 |
| Buy* | 3 | 190.00p | SI Trade |
12:33:40 - 12-May-26 |
| Unknown* | 0 | 190.00p | SI Trade |
12:33:40 - 12-May-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Apr 2026 9:30 am | RNS | Total Voting Rights |
| 29th Apr 2026 11:00 am | RNS-R | HUTCHMED Announces NDA Acceptance in China |
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |